Abstract:Human defensins are a family of small antimicrobial proteins found predominantly in leukocytes and epithelial cells that play important roles in the innate and adaptive immune defense against microbial infection. The most distinct molecular feature of defensins is cationicity, manifested by abundant Arg and/or Lys residues in their sequences. Sequence analysis indicates that Arg is strongly selected over Lys in α-defensins but not in β-defensins. To understand this Arg/Lys disparity in defensins, we chemically synthesized human α-defensin 1 (HNP1) and several HNP1 analogs where three Arg residues were replaced by each of the following six α-amino acids: Lys, ornithine (Orn), diaminobutyric acid (Dab), diaminopropionic acid (Dap), N,N-dimethyl-Lys (diMeLys), and homo-Arg (homoArg). In addition, we prepared human β-defensin 1 (hBD1) and Lys→ArghBD1 in which all four Lys residues were substituted for Arg. Bactericidal activity assays revealed the following. 1) Arg-containing HNP1 and Lys→ArghBD1 are functionally better than Lys-HNP1 and hBD1, respectively; the difference between Arg and Lys is more evident in the α-defensin than in the β-defensin and is more evident at low salt concentrations than at high salt concentrations. 2) For HNP1, the Arg/Lys disparity is much more pronounced with Staphylococcus aureus than with Escherichia coli, and the Arg-rich HNP1 kills bacteria faster than its Lys-rich analog. 3) Arg and Lys appear to have optimal chain lengths for bacterial killing as shortening Lys or lengthening Arg in HNP1 invariably becomes functionally deleterious. Our findings provide insights into the Arg/Lys disparity in defensins, and shed light on the cationicity of defensins with respect to their antimicrobial activity and specificity.

Structural Analysis of Human β-Defensin-1 and Its Significance in Urinary Tract Infection

Expression and Antimicrobial Function of Beta-Defensin 1 in the Lower Urinary Tract

[Advances in the Research of Human Defensins].

Recent advances in the research and development of human defensins.

High-level Production of Bioactive Human Beta-Defensin-4 in Escherichia Coli by Soluble Fusion Expression

Proteolytic Degradation of reduced Human Beta Defensin 1 generates a Novel Antibiotic Octapeptide

Cloning and Expression of Human Beta-Defensin-2 Gene in Escherichia Coli

Antimicrobial Characterization of Human -Defensin 3 Derivatives

Soluble fusion expression and characterization of bioactive human beta-defensin 26 and 27

Nucleotide Sequence and Expression of Rat β-Defensin-1: Its Significance in Diabetic Rodent Models

Production and characterization of recombinant human beta-defensin DEFB120.

High-level Expression of Soluble Human Β-Defensin-2 in Escherichia Coli

Fusion expression of human beta-defensin-2 from multiple joined genes in Escherichia coli.

The novel human β-defensin 114 regulates lipopolysaccharide (LPS)-mediated inflammation and protects sperm from motility loss.

Sa.84. Α-Defensins Inhibit Interleukin-1β Production

Serum β-Defensin 2, A Novel Biomarker for the Diagnosis of Acute Infections

173 Human Defensins - Small in Size but Big in Functionality

The Novel Human Beta-Defensin 114 Regulates Lipopolysaccharide (Lps)-Mediated Inflammation And Protects Sperm From Motility Loss

Three-dimensional structure of RK-1: a novel alpha-defensin peptide

Human Α-Defensin 6 Promotes Mucosal Innate Immunity Through Self-Assembled Peptide Nanonets.

Toward Understanding the Cationicity of Defensins